ROCA, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 5.518
AS - Asia 2.429
EU - Europa 1.685
SA - Sud America 497
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 46
OC - Oceania 7
Totale 10.343
Nazione #
US - Stati Uniti d'America 5.432
SG - Singapore 850
CN - Cina 830
BR - Brasile 410
UA - Ucraina 378
DE - Germania 338
HK - Hong Kong 285
IT - Italia 197
VN - Vietnam 191
GB - Regno Unito 140
RU - Federazione Russa 128
FR - Francia 107
FI - Finlandia 106
TR - Turchia 86
IE - Irlanda 79
PL - Polonia 66
CA - Canada 50
IN - India 44
AR - Argentina 37
CZ - Repubblica Ceca 36
BD - Bangladesh 35
IQ - Iraq 22
BE - Belgio 20
SE - Svezia 19
JP - Giappone 18
MX - Messico 17
NL - Olanda 17
ES - Italia 15
EC - Ecuador 14
CO - Colombia 12
SA - Arabia Saudita 11
ZA - Sudafrica 11
ID - Indonesia 10
AT - Austria 9
VE - Venezuela 9
MA - Marocco 8
DZ - Algeria 7
UZ - Uzbekistan 7
AU - Australia 6
PY - Paraguay 6
IR - Iran 5
JM - Giamaica 5
AZ - Azerbaigian 4
CL - Cile 4
EG - Egitto 4
EU - Europa 4
LT - Lituania 4
TN - Tunisia 4
BB - Barbados 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
HN - Honduras 3
NP - Nepal 3
PK - Pakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
PH - Filippine 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LY - Libia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
UG - Uganda 1
Totale 10.186
Città #
Fairfield 755
Ashburn 486
Singapore 432
Woodbridge 391
Jacksonville 316
Houston 311
Seattle 290
Hong Kong 281
Cambridge 257
Wilmington 248
Beijing 214
Chandler 202
Ann Arbor 179
San Jose 167
The Dalles 150
Princeton 146
New York 117
Nanjing 102
Helsinki 84
Los Angeles 83
Dublin 79
Istanbul 70
Dearborn 64
Lauterbourg 64
Warsaw 64
Ho Chi Minh City 59
Munich 55
Dallas 43
Chicago 42
Des Moines 42
Council Bluffs 41
Changsha 36
Nanchang 36
Hanoi 34
São Paulo 34
Moscow 33
San Diego 30
San Francisco 30
Shanghai 30
Hebei 29
Brescia 28
Redondo Beach 27
Santa Clara 27
Buffalo 26
Shenyang 25
London 24
Orem 24
Brno 22
Boardman 20
Brussels 19
Jinan 19
Turku 19
Denver 18
San Mateo 18
Atlanta 17
Montreal 17
Toronto 17
Tianjin 16
Brooklyn 15
Milan 15
Tokyo 15
Olomouc 14
Rio de Janeiro 13
Zhengzhou 13
Boston 12
Jiaxing 12
Nürnberg 12
Belo Horizonte 11
Kunming 11
Poplar 11
Stockholm 11
Dhaka 10
Dong Ket 10
Rome 10
Columbus 9
Guangzhou 9
Hangzhou 9
Washington 9
Amsterdam 8
Falls Church 8
Frankfurt am Main 8
Lanzhou 8
Mumbai 8
Ningbo 8
Nuremberg 8
Phoenix 8
Taizhou 8
Augusta 7
Charlotte 7
Chennai 7
Da Nang 7
Genoa 7
Jeddah 7
Lancaster 7
Manchester 7
Mexico City 7
Baghdad 6
Betim 6
Biên Hòa 6
Campinas 6
Totale 6.899
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 252
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 231
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 212
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 210
Acute functional reactivation of the language network during awake intraoperative brain mapping 209
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 209
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 204
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 196
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 194
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 191
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 191
Palbociclib inhibits proliferation of human adrenocortical tumor cells 190
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 190
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 189
Regression of advanced neuroendocrine tumors among patients receiving placebo 189
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 180
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 175
Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders 175
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 174
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 172
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 169
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 169
Serum vitamin D and prostate cancer prognosis: The story continues 168
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 168
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 168
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 166
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 164
Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer 162
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma 158
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 157
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies 155
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 153
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 153
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 152
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: Prediction of the response to the first-line chemotherapy 150
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 148
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 148
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 146
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study 144
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 143
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology 139
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 138
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 131
CT scanner for the pleural staging of pleural cancer: How accurate is this? 127
Malignant pleural mesothelioma: from the bench to the bedside 119
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 119
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? 118
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough 115
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 115
CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer 113
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions 111
False Negative Pleural Cytology in Patient with Malignant Pleurisies: Is Pleural EpCAM-Positive Microparticles a Complementary Tool for Diagnosis? 111
Onde elettromagnetiche ad alta frequenza e bassa intensit. nel trattamento delle ulcere cutanee: 8 casi clinici. 107
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort 106
Malignant pleural mesothelioma signs and symptoms 105
THE ASSOCIATION BETWEEN PROTEOMIC PROFILE DETECTED BEFORE 2ND/3RD LINE EGFR-TKIS AND RESPONSE TO 1ST LINE CHEMOTHERAPY 97
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 91
Pathologie pleurale 91
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER 89
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 79
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice 75
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 73
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation 72
Onde elettromagnetiche ad alta frequenza e bassa intensità nel trattamento delle ulcere cutanee: 8 casi clinici 69
Thoracic Cytological Specimens Obtained In Routine Clinical Practice And EGFR, Kras, Her2, Braf And Pi3kca Mutation Status In Metastatic Cancer Patients 69
Maintenance with Lanreotide in SCLC Patients, Expressing Somatostatine Receptors, after Response to First Line Therapy 66
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity 66
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration 65
Multigene Mutation Analysis Of Mediastinal Lymph Nodes Assessed By Endobronchial Ultrasound-Guided Needle Aspiration: A Prospective Study 65
PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS 65
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 64
Is DNA repair a potential target for effective therapies against malignant mesothelioma? 55
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 51
Totale 10.343
Categoria #
all - tutte 49.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022554 0 66 33 45 9 36 21 63 25 72 47 137
2022/2023589 85 24 16 44 53 130 3 74 105 1 24 30
2023/2024618 47 22 63 34 33 91 19 21 154 9 6 119
2024/20251.323 20 5 8 199 145 93 117 53 183 74 259 167
2025/20262.744 262 440 240 426 321 175 331 77 150 204 96 22
2026/2027117 66 51 0 0 0 0 0 0 0 0 0 0
Totale 10.343